Castle Biosciences
CSTL
CSTL
180 hedge funds and large institutions have $1.51B invested in Castle Biosciences in 2021 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 77 increasing their positions, 45 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2.38% less ownership
Funds ownership: 85.38% → 83.01% (-2.4%)
16% less call options, than puts
Call options by funds: $1.83M | Put options by funds: $2.18M
Holders
180
Holding in Top 10
2
Calls
$1.83M
Puts
$2.18M
Top Buyers
| 1 | +$35.9M | |
| 2 | +$32.6M | |
| 3 | +$28.4M | |
| 4 |
BlackRock
New York
|
+$24.1M |
| 5 |
ZCI
Zevenbergen Capital Investments
Edmonds,
Washington
|
+$19.4M |
Top Sellers
| 1 | -$68.5M | |
| 2 | -$62.7M | |
| 3 | -$24.7M | |
| 4 |
Millennium Management
New York
|
-$17.1M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$9.76M |